New evidence implicates salt-sensitive, natural antibiotics in lung mucosal defenses and may explain how a defective chloride channel leads to lung infections.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
di Sant′Agnese, P. et al. Sweat electrolyte disturbances associated with childhood pancreatic disease. Am. J. Med. 15, 777–784 (1953).
Quinton, P.M. Chloride impermeability in cystic fibrosis. Nature 301, 421–422 (1983).
Smith, J.J., Travis, S.M., Greenberg, E.P. & Welsh, M.J. Cystic fibrosis airway epithelia fail to kill bacteria because of abnormal airway surface fluid. Cell 85, 229–236 (1996).
Zasloff, M., Magainins, a class of antimicrobial peptides from Xenopusskin: Isolation, characterization of two active forms, and partial cDNA sequence of a precursor. Proc. Natl. Acad. Sci. USA 84, 5449–5453 (1987).
Bensch, K.W. et al. hBD-1: A novel beta-defensin from human plasma. FEBS Lett. 368, 331–335 (1995).
McCray, P.B. & Bentley, L. Human airway epithelia express a β-defensin. Am. J. Respir. Cell Mol. Biol. 16, 343–349 (1997).
Goldman, M.J. et al. Human β-defensin-1 is a salt-sensitive antibiotic in lung that is inactivated in cystic fibrosis. Cell 88, 553–560 (1997).
Boucher, R.C. et al. Na+ transport in cystic fibrosis respiratory epithelia. Abnormal basal rate and response to adenylate cyclase activation. J. Clin. Invest. 78, 1245–1252 (1986).
Basbaum, C.B., Jany, B. & Finkbeiner, W.E. The serous cell. Annu. Rev. Physiol. 52, 97–113 (1990).
Engelhardt, J.F. et al. Submucosal glands are the predominant site of CFTR expression in the human bronchus. Nature Genet. 2, 240–248 (1992).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Wine, J. A sensitive defense: Salt and cystic fibrosis. Nat Med 3, 494–495 (1997). https://doi.org/10.1038/nm0597-494
Issue Date:
DOI: https://doi.org/10.1038/nm0597-494